Have a personal or library account? Click to login
Role of transurethral resection of the prostate in the management of prostate cancer Cover

Role of transurethral resection of the prostate in the management of prostate cancer

Open Access
|May 2016

References

  1. 1. Dae Keun Kim, Sang Jin Kim, Hong Sang Moon, et al. The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy. www.kjurology.org DOI:10.4111/kju.2010.51.5.313.10.4111/kju.2010.51.5.313287388420495693
  2. 2. S Radhakrishnan, TJ Dorkin, N Sheikh & DR Greene. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies. Prostate Cancer and Prostatic Diseases 2004:7;338–342.10.1038/sj.pcan.450075615365579
  3. 3. Koenraad van Renterghem, Gommert Van Koeveringe, Ruth Achten, Philip van Kerrebroeck. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction. European urology 2008: 54;1385-1392.10.1016/j.eururo.2008.06.06918599187
  4. 4. Tristan Dellavedova, Rolando Ponzano, Laura Racca, Federico Minuzzi and Mariana Dominguez. Prostate cancer as incidental finding in transurethral resection. Oncologic Urology Arch. Esp. Urol. 2010:63(10);855-861.10.4321/S0004-06142010001000005
  5. 5. Koenraad M.L.E. van Renterghem, Philip E.V.A. van Kerrebroeck and Gommert A. Van Koeveringe. Role and current situation of turp in patients with elevated psa; Special article Arch. Esp. Urol. 2010:63(6);411-419.10.4321/S0004-06142010000600001
  6. 6. Paolo Puppo, Carlo Introini, Paolo Calvi, Angelo Naselli. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol. 2006;49(5):873-878.10.1016/j.eururo.2005.12.06416439052
  7. 7. Djavan B. Prostate Biopsies and the Vienna Nomograms. European Urology. 2006:Suppl5;500–510.10.1016/j.eursup.2006.02.018
  8. 8. Werahera PN, Sullivan K, La Rosa FG, at al: Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume. International journal of clinical and experimental pathology. 2012;5:892-899.
  9. 9. Nelson AW, Harvey RC, Parker RA, et al. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. PLoS One. 2013;8(2):e57480.10.1371/journal.pone.0057480358383623460864
  10. 10. Van Renterghem K, Van Koeveringe G, Achten R, et al. A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies. International urology and nephrology. Int Urol Nephrol. 2010;42:29-38.10.1007/s11255-009-9596-z284497219496018
DOI: https://doi.org/10.1515/amma-2016-0008 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 205 - 208
Submitted on: Oct 20, 2015
|
Accepted on: Jan 5, 2016
|
Published on: May 20, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Attila Szollosi, Orsolya Martha, Lorand Denes, Arpad Oliver Vida, Adrian Maier, Zoltan Pavai, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.